1. Home
  2. Investor Relations
  3. Announcements and Circulars
Announcements and Circulars Financial Reports Prospectus Corporate Governance Contact IR
VOLUNTARY ANNOUNCEMENT - LAUNCH OF PHASE III OSTEOSARCOMA CLINICAL TRIAL FOR C019199 TABLETS BY HAIXI PHARMACEUTICALS
2026-07-09
Download
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026
2026-07-06
Download
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
2026-06-04
Download
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2026-05-27
Download
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 27 MAY 2026, CHANGE OF DIRECTORS, ELECTION OF CHAIRMAN AND APPOINTMENT OF SENIOR MANAGEMENT, CHANGE IN COMPOSITION OF BOARD COMMITTEE AND ABOLISHMENT OF THE BOARD OF SUPERVISORS
2026-05-27
Download
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
2026-05-07
Download
About Us
Technology
Products
News
Investor Relations
Careers
Contact Us

Fujian Haixi Pharmaceutical Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min)-Non-operating-2023-0063

Some texts and images on this website are sourced from the Internet for sharing and learning purposes only. If any content infringes your rights and interests, please notify us promptly, and we will handle or remove the relevant materials without delay.